glp-1 medicare coverage Recent Trends in Use and Spending in GLP-1s and The Payer Predicament

It is not approved or intended for human or animal use, consumption, therapeutic use, clinical application, or diagnostic purposes

muciniphila in Protecting Against Obesity and Metabolic Syndrome The obesity is related to gut dysbiosis as an imbalance between energy consumption and expenditure favors the prevalence of pathobiont bacteria (4143)

Whether someday, a machine learning model could know that you have bipolar disorder before you even have a mood episode

Treatment Treating the physical fatigue of fibromyalgia is not easy

Association Between Gut Akkermansia and Metabolic Syndrome is Dose-Dependent and Affected by Microbial Interactions: A Cross-Sectional Study

What Our Happy Patients Are Saying 98% love their experience You have questions, we have answers